Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-08 Sale | 2024-03-13 06:04 am | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 29,491 | $26.59 | $784,248 | 156,800 (Direct) | View |
| 2024-03-08 Sale | 2024-03-13 06:04 am | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 109,601 | $26.11 | $2,861,373 | 169,542 (Direct) | View |
| 2024-03-11 Sale | 2024-03-12 9:58 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 2,615 | $25.65 | $67,082 | 150,560 (Direct) | View |
| 2024-03-08 Sale | 2024-03-12 9:57 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 88,924 | $26.19 | $2,329,007 | 129,138 (Direct) | View |
| 2024-03-08 Sale | 2024-03-12 9:56 pm | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 429,730 | $25.89 | $11,125,776 | 754,536 (Direct) | View |
| 2024-03-11 Sale | 2024-03-12 9:42 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 2,081 | $25.7 | $53,482 | 152,352 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:57 pm | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 9,086 | $25.85 | $234,873 | 554,385 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:56 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 2,373 | $25.85 | $61,342 | 154,433 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:56 pm | Dyne Therapeutics Inc. | DYN | HIGH SUSANNA GATTI Chief Operating Officer | 1,591 | $25.85 | $41,127 | 186,291 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:52 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 9,921 | $25.86 | $256,585 | 153,175 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:50 pm | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 2,434 | $25.85 | $62,919 | 141,184 (Direct) | View |
| 2024-03-07 Sale | 2024-03-11 9:45 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 2,273 | $25.85 | $58,757 | 121,955 (Direct) | View |
| 2024-03-01 Sale | 2024-03-05 5:08 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 46,534 | $30.05 | $1,398,347 | 6,545,479 (Indirect) | View |
| 2024-03-01 Sale | 2024-03-05 5:07 pm | Dyne Therapeutics Inc. | DYN | Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 46,534 | $30.05 | $1,398,347 | 2,306,079 (Indirect Direct) | View |
| 2024-02-29 Sale | 2024-03-01 9:38 pm | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 100,000 | $28.96 | $2,895,519 | 1,052,995 (Direct) | View |
| 2024-02-29 Sale | 2024-03-01 9:37 pm | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 28,528 | $28.46 | $811,865 | 167,878 (Direct) | View |
| 2024-02-29 Sale | 2024-03-01 9:37 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 12,740 | $28.05 | $357,296 | 133,539 (Direct) | View |
| 2024-02-26 Sale | 2024-02-28 7:15 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 807,838 | $24.3 | $19,626,903 | 864,487 (Indirect) | View |
| 2024-02-26 Sale | 2024-02-28 7:13 pm | Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 807,838 | $24.3 | $19,626,903 | 6,562,578 (Indirect Direct) | View |
| 2024-02-28 Sale | 2024-02-28 5:06 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 407 | $25 | $10,175 | 163,096 (Direct) | View |
| 2024-02-21 Sale | 2024-02-23 6:59 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 500,789 | $22.64 | $11,339,780 | 920,843 (Indirect) | View |
| 2024-02-21 Sale | 2024-02-23 6:58 pm | Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund II L.P. Atlas Venture Associates Opportunity II LP Atlas Venture Associates Opportunity II LLC 10% Owner | 500,789 | $22.64 | $11,339,780 | 7,273,405 (Indirect Direct) | View |
| 2024-02-15 Sale | 2024-02-20 6:36 pm | Dyne Therapeutics Inc. | DYN | Rhodes Jason P Director | 510,152 | $23.26 | $11,867,292 | 9,359,331 (Indirect) | View |
| 2024-02-15 Sale | 2024-02-20 6:35 pm | Dyne Therapeutics Inc. | DYN | Atlas Venture Fund XI L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC 10% Owner | 510,152 | $23.26 | $11,867,292 | 6,815,965 (Direct) | View |
| 2024-02-12 Sale | 2024-02-14 4:27 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 5,493 | $25.07 | $137,710 | 163,503 (Direct) | View |
| 2024-01-26 Sale | 2024-01-26 7:49 pm | Dyne Therapeutics Inc. | DYN | Farwell Wildon Chief Medical Officer | 100 | $25 | $2,500 | 168,996 (Direct) | View |
| 2024-01-26 Sale | 2024-01-26 7:48 pm | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 20,000 | $24.53 | $490,510 | 172,146 (Direct) | View |
| 2024-01-26 Sale | 2024-01-26 7:47 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 13,000 | $24.34 | $316,420 | 136,968 (Direct) | View |
| 2024-01-09 Purchase | 2024-01-11 4:31 pm | Dyne Therapeutics Inc. | DYN | Kersten Dirk Director 10% Owner | 1,714,285 | $17.5 | $29,999,988 | 1,428,571 (Indirect) | View |
| 2024-01-03 Sale | 2024-01-04 9:49 pm | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 269,719 | $18.66 | $5,032,915 | 711,370 (Direct) | View |
| 2024-01-03 Sale | 2024-01-04 9:48 pm | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 87,779 | $18.57 | $1,629,985 | 240,332 (Direct) | View |
| 2024-01-02 Sale | 2024-01-04 9:47 pm | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 31,900 | $16.59 | $529,194 | 242,683 (Direct) | View |
| 2024-01-03 Sale | 2024-01-04 9:46 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 13,000 | $18.81 | $244,530 | 149,968 (Direct) | View |
| 2023-12-14 Sale | 2023-12-14 4:59 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks | 2,376 | $12.02 | $28,560 | 124,228 (Direct) | View |
| 2023-12-11 Sale | 2023-12-12 5:35 pm | Dyne Therapeutics Inc. | DYN | Scalzo Richard William See Remarks | 1,380 | $10.72 | $14,794 | 126,604 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership(A) | 2024-04-04 9:07 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Cox John CEO & President | 0 | $0 | 5,000 (Direct) | View |
| 2023-07-11 Option Award | 2024-04-04 9:06 pm | N/A 2033-07-10 | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 35,000 | $0 | 35,000 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 4:24 pm | N/A 2034-03-24 | Dyne Therapeutics Inc. | DYN | Cox John See Remarks | 679,853 | $0 | 679,853 (Direct) | View |
Ownership | 2024-03-27 4:13 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Cox John See Remarks | 0 | $0 | 10,000 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-13 06:04 am | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 107,825 | $0 | 169,542 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-13 06:04 am | N/A N/A | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 107,825 | $5.54 | 169,542 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 9:57 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 86,252 | $0 | 129,138 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 9:57 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 86,252 | $5.54 | 129,138 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 9:56 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 413,343 | $0 | 754,536 (Direct) | View |
| 2024-03-08 Exercise | 2024-03-12 9:56 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 413,343 | $5.54 | 754,536 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:38 pm | N/A 2030-07-30 | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 100,000 | $0 | 1,052,995 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:38 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 100,000 | $5.54 | 1,052,995 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:37 pm | N/A 2029-02-25 | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 28,528 | $0 | 167,878 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:37 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 28,528 | $0.73 | 167,878 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:37 pm | N/A 2030-01-05 | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 12,740 | $0 | 133,539 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-01 9:37 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 12,740 | $1.03 | 133,539 (Direct) | View |
| 2024-01-29 Gift | 2024-01-31 4:18 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 21,500 | $0 | 563,471 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-26 7:48 pm | N/A 2029-02-25 | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 20,000 | $0 | 172,146 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-26 7:48 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 20,000 | $0.73 | 172,146 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-26 7:47 pm | N/A 2030-01-05 | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 13,000 | $0 | 136,968 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-26 7:47 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 13,000 | $1.03 | 136,968 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 9:49 pm | N/A 2030-01-05 | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 269,719 | $0 | 711,370 (Direct) | View |
| 2024-01-04 Exercise | 2024-01-04 9:49 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 200,000 | $5.54 | 711,370 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 9:49 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Brumm Joshua T CEO & President | 69,719 | $1.03 | 711,370 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 9:48 pm | N/A 2030-01-05 | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 68,000 | $0 | 240,332 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 9:48 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Beskrovnaya Oxana Chief Scientific Officer | 68,000 | $1.03 | 240,332 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 9:47 pm | N/A 2029-02-25 | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 20,000 | $0 | 242,683 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 9:47 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer | 20,000 | $0.73 | 242,683 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 9:46 pm | N/A 2030-01-05 | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 13,000 | $0 | 149,968 (Direct) | View |
| 2024-01-03 Exercise | 2024-01-04 9:46 pm | N/A N/A | Dyne Therapeutics Inc. | DYN | Scalzo Richard William SVP, Head of Finance & Admin. | 13,000 | $1.03 | 149,968 (Direct) | View |